Evidence map›Paper›PMID 42729736›Full record

ArticleACS omega2026

Novel Phenanthraquinone Derivative from Antarctic Lichen

Bowon Jung, Jinkyu Lee, Yunji Kang, Yoon Seo Jang, Ki Hyun Kim, Ui Joung Youn, Hee Ho Park, Boram Son, Seulah Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bowon JungDepartment of Convergent Biotechnology and Advanced Materials Science, BK21 Interdisciplinary Program in IT-Bio Convergence System, Kyung Hee University, Yongin 17104, Republic of Korea.
Jinkyu LeeDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Yunji KangDepartment of Bio & Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea.
Yoon Seo JangSchool of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Ki Hyun KimSchool of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID https://orcid.org/0000-0002-5285-9138
Ui Joung YounDivision of Life Sciences, Korea Polar Research Institute ; Department of Polar Sciences, University of Science and Technology, Incheon 21990, Republic of Korea.
Hee Ho ParkDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Boram SonDepartment of Bio & Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea.
Seulah LeeDepartment of Convergent Biotechnology and Advanced Materials Science, BK21 Interdisciplinary Program in IT-Bio Convergence System, Kyung Hee University, Yongin 17104, Republic of Korea.ORCID https://orcid.org/0000-0002-4657-5104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is one of the most challenging malignancies in modern drug development, as its poor prognosis and limited therapeutic options create an urgent demand for innovative treatments. To address this, Antarctic lichensknown for their diverse pharmacological activities, including anticancer, antioxidant, antimicrobial, and anti-inflammatory effectswere selected as a natural source for potential lead compounds. Extensive chemical analysis of

Identifiers

PMID42729736
PMCPMC13563618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.